B

Baillie Gifford

1687 employees

Baillie Gifford is an independently owned firm that focuses on investment and asset management.

Investor insights

Sectors invested in

Biotechnology26
Health Care20
Transportation15
Medical14
Artificial Intelligence14
E-Commerce13
FinTech12
Software12
Machine Learning10
Finance10
Electric Vehicle9
Health Diagnostics8
InsurTech8
Financial Services8
technology8
Logistics7
Supply Chain Management7
Service Industry7
Manufacturing6
autonomy6

Funding rounds participated in

$184M sweet spot round size

Most of their 108 investments are in rounds between $114M and $300M

Investor type

Investment Bank
Venture Capital

Basic info

Industry

financial services

Sectors

Financial Services
Equity investing
Finance
Multi asset and fixed income investing
long-term investing
ESG
Asset Management
Investment management
Asset management

Date founded

1908

Investments made

B

Boston Metal raised $122M on September 6, 2023

Investors: Aramco Ventures, Goehring & Rozencwajg Associates, LLC, Breakthrough Energy Ventures, M&G, Prelude Ventures and Baillie Gifford

B

Bending Spoons raised $109M on August 3, 2023

Investors: NUO Capital, Tamburi Investment Partners, Cox Enterprises and Baillie Gifford

M

McMakler raised $22M on June 30, 2023

Investors: Israel Growth Partners, Warburg Pincus LLC, Frog Capital and Baillie Gifford

J

Joby Aviation raised $180M on May 3, 2023

Investors: Baillie Gifford

H

HeartFlow, Inc raised $215M on April 6, 2023

Investors: HEALTHCOR LTD, Capricorn Investment Group, Hayfin Capital Management LLP, Wellington Management, Martis Capital and Baillie Gifford

S

Stripe raised $6.5B on March 15, 2023

Investors: Founders Fund, General Catalyst, Temasek, BDT & MSD Partners, Thrive Capital, Goldman Sachs Asset Management, GIC, Andreessen Horowitz and Baillie Gifford

D

Delhivery raised $115M on March 2, 2023

Investors: The New York Community Trust, Societe Generale and Baillie Gifford

B

BillionToOne raised $49M on December 15, 2022

Investors: Libertus Capital, Time BioVentures, Adams Street Partners, Neotribe Ventures, Norwest Venture Partners, Hummingbird Ventures and Baillie Gifford

U

Undisclosed raised $200M on October 28, 2022

Investors: Temasek, Lowercarbon Capital, Refactor Capital and Baillie Gifford

R

Recursion Pharmaceuticals raised $150M on October 25, 2022

Investors: Laurion Capital Management LP, The Invus Group and Baillie Gifford

FAQ